Mesna Uses, Dosage, Side Effects and Interactions
Mesnex
Mesnex was approved by the FDA in December 1988. An FDA-approved generic with the same active ingredient is listed.
Mesna is a cytoprotective (bladder-protecting) agent used alongside ifosfamide chemotherapy to reduce the risk of hemorrhagic cystitis (serious bladder bleeding).
Quick links
Ask Anything About MesnaType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Mesna in Short
- Drug class Cytoprotective Agent How the FDA classifies it
What it treatsMesna — available as both an injection (Mesna, Mesnex) and an oral tablet (Mesna, Mesnex) — is used to protect the bladder during ifosfamide chemotherapy. Specifically, it reduces the risk of ifosfamide-induced hemorrhagic cystitis, a condition where toxic byproducts of ifosfamide damage the lining of the bladder and…
- How you get it Prescription only
- Comes asInjection and tabletAvailable strengths
Injection (into a vein)
- 100 mg/mL
Tablet (by mouth)
- 400 mg
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What Medicaid pays
- Generic$59.33 a tablet
- Mesnex tablets: Medicaid paid $71.27 a tablet
What state Medicaid programs paid, before rebates. Not your price See every price+ 1 more price detailShow fewer price details
- Injections: no national price found
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Mesna (Mesnex) is a bladder-protecting medicine given with ifosfamide chemotherapy. It binds and neutralizes ifosfamide’s toxic byproducts in the urine to help prevent hemorrhagic cystitis (serious bladder bleeding), and it is a standard companion to ifosfamide, not a cancer treatment, on the U.S. market since about 1987 with FDA-approved generics listed. Most people tolerate it well, and its usual effects (nausea, tiredness, headache) are hard to tell apart from the chemotherapy itself. Watch for a serious allergic or skin reaction (trouble breathing, swelling, or a blistering, peeling rash), which can strike at the first dose or months later and needs emergency care.
Key Takeaways From the HelloPharmacist Team
- Expect mesna with each ifosfamide dose, all by IV (into a vein) or IV then tablets at set hours, every ifosfamide day.
- Call your care team if you vomit within two hours of a mesna tablet; you may need a repeat dose or IV mesna.
- Report pink or red urine promptly; mesna lowers ifosfamide’s bladder risk but does not stop bleeding from other causes, like low platelets.
- Tell any lab you are on mesna, since it can falsely skew urine ketone, urine vitamin C and CPK (muscle enzyme) blood tests.
Patient Information Guide for Mesna
What It’s Used For
Mesna is a cytoprotective (bladder-protecting) agent used specifically to prevent a serious complication of ifosfamide chemotherapy.
- Ifosfamide-induced hemorrhagic cystitis (bladder bleeding): Both Mesna injection and Mesna/Mesnex tablets are approved to reduce the risk of this condition, in which toxic breakdown products of ifosfamide damage the bladder lining and cause bleeding.
- Limitation: Mesna is not approved to prevent or treat blood in the urine caused by other conditions, such as thrombocytopenia (low platelet counts) or other diseases.
How It Works
Ifosfamide is broken down in the body into harmful byproducts — particularly acrolein and 4-hydroxy-ifosfamide — that end up in the urine and attack the lining of the bladder. Mesna works by chemically binding to these toxic metabolites in the urinary tract, converting them into harmless compounds before they can damage bladder tissue. It essentially acts as a targeted chemical neutralizer, protecting only the bladder without interfering with ifosfamide's cancer-fighting activity elsewhere in the body.
Drug Class
Drug Class
- Cytoprotective Agent
From Mesna’s FDA label.
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Cytoprotective Agent
The main drug class the FDA gives it. It is the class named on the drug’s label.
What It Does in the Body
Physiologic effect (PE)None listed for Mesna in the FDA’s index.
From our Patient Information GuideIfosfamide is broken down in the body into harmful byproducts — particularly acrolein and 4-hydroxy-ifosfamide — that end up in the urine and attack the lining of the bladder. Read How Mesna Works
A change it makes in how the body works.
Drug Family
WHO ATC classification- Mucolytics
- Detoxifying agents for antineoplastic treatment
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The drug class comes from Mesna’s FDA label. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.
Dosage
Mesna is always given in close coordination with ifosfamide, and the schedule is repeated on every day that ifosfamide is administered. There are two approaches:
- All-IV schedule: Mesna injection is given as three intravenous bolus injections — at the time of ifosfamide and at set intervals afterward (4 and 8 hours later).
- IV-then-oral schedule: Mesna injection is given as one IV bolus at the time of ifosfamide, followed by oral mesna tablets at timed intervals (2 and 6 hours later). Food does not affect the urinary effectiveness of the oral tablets. If you vomit within two hours of an oral dose, contact your care team — you may need a repeat dose or a switch to IV.
If your ifosfamide dose is ever adjusted up or down, the mesna dose must be adjusted in proportion. Always follow the exact schedule your prescriber provides.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Mesna Injection
Protecting the bladder from bleeding caused by ifosfamide
People receiving ifosfamide · Intravenous schedule only Usual dose 240 mg/m2 of mesna injection at 0, 4 and 8 hours
- Ifosfamide 1.2 g/m2 at 0 hours
Good to know
Repeat each day ifosfamide is given; keep the mesna to ifosfamide ratio if the ifosfamide dose changes
People receiving ifosfamide · Intravenous then oral schedule Usual dose 240 mg/m2 of mesna injection at 0 hours, then 480 mg/m2 of mesna tablets at 2 and 6 hours
- Ifosfamide 1.2 g/m2 at 0 hours
Good to know
Efficacy and safety of this ratio not established for ifosfamide daily doses higher than 2 g/m2; repeat the dose or use IV mesna if vomiting within two hours of oral dose
IV means given into a vein (intravenous).
Mesna Taken by Mouth
Protecting the bladder from bleeding caused by ifosfamide
People receiving ifosfamide · Intravenous schedule only Usual dose 240 mg/m2 of Mesnex injection at 0, 4 and 8 hours
- Ifosfamide 1.2 g/m2 at 0 hours
Good to know
Repeat each day ifosfamide is given; keep the ratio if the ifosfamide dose changes
People receiving ifosfamide · Intravenous then oral schedule Usual dose 240 mg/m2 of Mesnex injection at 0 hours, then 480 mg/m2 of Mesnex tablets at 2 and 6 hours
- Ifosfamide 1.2 g/m2 at 0 hours
Good to know
Not established for ifosfamide daily doses higher than 2 g/m2; repeat the dose or use IV Mesnex if vomiting within two hours of oral dose
IV means given into a vein (intravenous).
Side Effects
Because mesna is given alongside ifosfamide chemotherapy, some side effects may come from ifosfamide rather than mesna alone. The most commonly reported effects include:
Common side effects
- Nausea and vomiting
- Fatigue and weakness
- Constipation or diarrhea
- Fever
- Headache
- Dizziness
- Loss of appetite
- Injection site reactions (with IV use)
- Low blood cell counts (leukopenia, anemia, thrombocytopenia, granulocytopenia)
- Somnolence (drowsiness)
When to get medical help
- Signs of a severe allergic reaction (anaphylaxis): difficulty breathing, rapid heart rate, low blood pressure, swelling — seek emergency help immediately
- Serious skin reactions such as widespread rash with blistering or peeling, mouth sores, or skin that looks burned — stop treatment and get medical help
- Blood in your urine (hematuria) — notify your care team promptly
- Signs of low blood pressure: lightheadedness, fainting, or feeling very weak
- Unusual bleeding or bruising, or signs of low blood counts (fever, chills, extreme tiredness)
Seek immediate medical attention for signs of a severe allergic reaction (trouble breathing, chest tightness, swelling, sudden low blood pressure) or serious skin reactions such as widespread blistering or peeling — these require stopping mesna right away.
Warnings and Precautions
- Severe allergic reactions (anaphylaxis): Mesna can cause life-threatening allergic reactions, including fever, low blood pressure, rapid heart rate, difficulty breathing, swelling, and organ effects. These can happen on the first dose or after months of use. Stop treatment and get emergency care immediately if these occur.
- Serious skin reactions: Rare but dangerous skin conditions — including Stevens-Johnson syndrome and toxic epidermal necrolysis (widespread blistering and skin loss) — have been reported. Discontinue mesna and seek urgent care if a severe rash, blistering, or mouth sores develop.
- Benzyl alcohol toxicity in newborns: Mesna injection contains benzyl alcohol, which has caused fatal reactions (including seizures, breathing failure, and cardiovascular collapse) in premature and low-birth-weight newborns. Mesna injection must not be used in these infants.
- Lab test interference: Mesna can cause false-positive urine ketone tests, falsely low CPK (creatinine phosphokinase) blood test results, and false-positive ascorbic acid urine tests. Alert any lab that you are on mesna before testing.
- History of thiol compound reactions: Mesna belongs to the thiol (sulfur-containing) drug class. Patients who have reacted to other thiol drugs may be at increased risk, though this is not fully established.
Interactions
No formal clinical drug interaction studies have been conducted with mesna. However, there are important considerations:
- Urine ketone tests (nitroprusside-based dipsticks): Mesna can produce a false-positive result — tell your care team before any urine testing.
- CPK (creatinine phosphokinase) blood tests using thiol-based reactivation: Mesna may cause falsely low CPK readings — inform your lab.
- Ascorbic acid urine screening tests (Tillman's reagent-based): Mesna can produce false-positive results — alert your healthcare team.
Interactions Listed in the FDA-Approved Label
From the Mesna prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
What happensNo clinical drug interaction studies have been conducted with mesna injection.
Read the label’s full interactions text
7 DRUG INTERACTIONS No clinical drug interaction studies have been conducted with mesna injection.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Allergy to mesna or its ingredients: Do not use mesna if you are allergic to mesna or any component of the injection or tablets, including benzyl alcohol (in the injection).
- History of reactions to thiol compounds (such as amifostine): Tell your doctor — there may be an increased risk of hypersensitivity.
- Pregnancy: Ifosfamide, used alongside mesna, can harm a fetus. Females of reproductive potential must use effective contraception during treatment and for 6 months after the last dose. Pregnancy should be confirmed negative before starting treatment.
- Breastfeeding: Do not breastfeed during treatment or for at least 1 week after the last dose of mesna or ifosfamide.
- Males with reproductive-age partners: Use effective contraception during treatment and for 3 months after the last dose.
- Premature newborns and low-birth-weight infants: Mesna injection must be avoided in these patients due to benzyl alcohol toxicity risk.
- Older adults: Dose selection should be approached cautiously given the greater likelihood of reduced kidney, liver, or heart function in this age group.
- Kidney or liver impairment: No formal studies have been done — your care team will monitor you closely.
Overdose
There is no known antidote for a mesna overdose. Taking too much can cause nausea, vomiting, diarrhea, and fever. Very high doses have also been associated with hypersensitivity reactions including low blood pressure, shortness of breath, rash, and flushing. If an overdose is suspected, contact a poison control center or emergency services immediately.
Half-Life and How Your Body Processes It
When taken orally, mesna is absorbed within 1.5 to 4 hours (free mesna) and reaches full absorption within 3 to 7 hours (total mesna), with oral bioavailability averaging about 58% for free mesna and 89% for total mesna. After IV administration, mesna distributes widely throughout body water. It is rapidly converted in the body to its main metabolite, mesna disulfide (dimesna). Both mesna and dimesna are eliminated through the urine — about one-third of an IV dose appears in the urine as each form within 24 hours. Mesna clears from the blood quickly, with a half-life of about 22 minutes; dimesna clears more slowly, with a half-life of about 70 minutes.
Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Mesna: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Mesna — the kind of thing our pharmacy team would talk through with you at the counter.
Why am I being given mesna — is it part of my cancer treatment?
What side effects should I expect, and which ones mean I need to call someone right away?
What happens if I miss a tablet dose or vomit shortly after taking it?
I've heard mesna can interfere with lab tests — what does that mean for me?
Can I breastfeed while on mesna?
I'm worried about my baby — I've seen something about benzyl alcohol. What should I know?
Is mesna available over the counter?
When was mesna first available?
Who makes mesna?
What is the brand name of mesna?
What is the generic name of Mesnex?
What drug class is mesna?
Is there a generic version of mesna?
What strengths does mesna come in?
How much does mesna cost?
Is there a mesna shortage?
Where can I read the mesna prescribing information (package insert)?
Is mesna gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Mesna
Skip the scrolling. Ask in your own words and get an answer from Mesna’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Mesna’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Mesna on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Mesna Forms and Strengths (How It Comes)
Mesna comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Mesna inactive ingredients by manufacturer.
Injection
How this form is used
- Mesna injection is used intravenously to reduce the risk of ifosfamide-induced hemorrhagic cystitis (bladder bleeding)
- Mesnex injection is used intravenously as a cytoprotective agent given alongside ifosfamide chemotherapy
- Mesna injection can be used as the sole route (three IV bolus doses per ifosfamide cycle) or as the first dose in a combined IV-then-oral regimen
- Mesna injection is given as intravenous bolus (rapid) injections timed around each ifosfamide dose — at the time of ifosfamide and again at set intervals afterward
- Mesnex injection dosing is repeated every day that ifosfamide is administered; if the ifosfamide dose changes, the mesna dose ratio must stay the same
- Mesna injection contains benzyl alcohol — avoid use in premature neonates and low-birth-weight infants
- Maintain adequate fluid intake and monitor urine for blood (hematuria) throughout treatment, as directed by your care team
Tablet
How this form is used
- Mesna tablets are used orally as part of a combined IV-then-oral regimen to reduce the risk of ifosfamide-induced hemorrhagic cystitis
- Mesnex tablets are taken after an initial Mesnex injection dose, at timed intervals following ifosfamide administration
- Mesna tablets are taken orally at specific time points after the initial IV mesna dose — follow your prescriber's exact schedule
- Food does not affect how well oral mesna works in the urine, so tablets may be taken with or without food
- If you vomit within two hours of taking a mesna tablet, contact your care team immediately — you may need to repeat the dose or receive IV mesna instead
- The combined IV-and-oral regimen with Mesnex tablets has not been established as effective for higher ifosfamide doses — your care team will determine the appropriate regimen
Mesna on the U.S. Market: Products, Makers and Brands
How Mesna appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
8 companies list 12 Mesna product records with the FDA, mostly as injection, tablet; the earliest marketing or approval year on record is 1987. The one brand name in the directory today is Mesnex; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Mesna Is Used (Medicaid Data)
How many Mesna prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Mesna prescribed? Of the 1,682 medications we measure, Mesna ranks #1,356 by Medicaid prescriptions — more than 19% of them.
Utilization by Mesna product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
mesna 100 MG/ML Injectable Solution Most dispensed
5 of 23 listed NDCs had Medicaid claims. RxNorm 204870
mesna 400 MG Oral Tablet
2 of 3 listed NDCs had Medicaid claims. RxNorm 142113
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 7 of the 26 listed Mesna NDCs had Medicaid claims.
Compare Mesna Products
A representative set of FDA-listed product records for Mesna — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 100 mg/mL | Intravenous | Bamboo US Bidco LCC | NDA | View NDC → |
| 100 mg/mL | Intravenous | Baxter Healthcare Company × 4 listings | NDA | View NDC → |
| 100 mg/mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 💊Tablet | ||||
| 400 mg | Oral | Baxter Healthcare Company | NDA | View NDC → |
| 400 mg | Oral | Ingenus Pharmaceuticals, LLC | ANDA | View NDC → |
Showing 12 of 12 products — FDA National Drug Code Directory. See every product, package size and price: browse all 12 Mesna NDCs →
Mesna Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Mesna — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Mesna are febrile neutropenia, pyrexia, neutropenia; about 97% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Mesna in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Mesna FDA Approval History
How Mesna went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Mesna was first approved by the FDA in 1987 (Brand: IFEX/MESNEX KIT · Baxter Hlthcare); the first generic version was approved in 2001. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Mesna Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Mesna recalls since July 2021.
✅No Mesna recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Mesna in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 2
- Strengths
- 3
- Forms in current FDA listings
- 2 of 2
RxCUI 44 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Mesna Supply and Shortage Status
Whether Mesna is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Medicaid Pays for Mesna
CMS’s weekly pharmacy survey (NADAC) has no price for Mesna, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.
No price was found for Mesna injections, so the prices below are for the tablets only.
| Form | Strength | Version | What Medicaid paid | |
|---|---|---|---|---|
| Tablet · Oral | 400 mg | Generic | $59.33 per tablet | NDC details & Medicaid use |
| Tablet · Oral | 400 mg | Mesnex (brand) | $71.27 per tablet | NDC details & Medicaid use |
Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.
Mesna Brand Names
Mesna has one brand name on record: Mesnex. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Mesna: Manufacturers and Labelers
8 companies list Mesna products with the FDA. By number of product records, the largest are Baxter Healthcare Company, Bamboo US Bidco LCC, Eugia US LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Mesna Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Baxter Healthcare Corporation is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →